297 Results

People

  1. Giralt
    Giralt
  2. Lesokhin
    Lesokhin
  3. Mauro
    Mauro
  4. Landau
    Landau
  5. Hassoun
    Hassoun
  6. Korde
    Korde
  7. Chung
    Chung
  8. Mailankody
    Mailankody
  9. Hultcrantz
    Hultcrantz
  10. Shah
    Shah

Groups

  1. Department of Medicine (297)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (275)
  4. Adult Leukemia (113)
  5. Myeloma (77)
  6. Survivorship Research (71)
  7. Hematologic Malignancies Research (69)
  8. Bone Marrow Transplant (64)
  9. Lymphoma (62)
  10. Sloan Kettering Institute Postdocs (48)
  1. "Clinical Lymphoma, Myeloma and Leukemia"
  2. "Department of Medicine"
Formats
  1. Meeting Abstract (235)
  2. Journal Article (54)
  3. Review (4)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Guidelines (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (297)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (275)
  4. Adult Leukemia (113)
  5. Myeloma (77)
  6. Survivorship Research (71)

More Groups

People
  1. Sergio Giralt (48)
  2. Alexander Lesokhin (44)
  3. Michael Mauro (43)
  4. Heather Landau (42)
  5. Hani Hassoun (40)
  6. Malin Hultcrantz (37)

More People

Years
  1. 2024 (2)
  2. 2023 (58)
  3. 2022 (53)
  4. 2021 (37)
  5. 2020 (29)
  6. 2019 (36)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (297)
Publishers
  1. Elsevier Inc. (297)

Results (297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comparison of 3-year follow-up of ZUMA-5 (axicabtagene ciloleucel) with SCHOLAR-5 in relapsed/refractory follicular lymphoma
    Editorial

    Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Owen, J.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Racial disparities in mycosis fungoides/Sézary syndrome–A single-center observational study of 292 patients
    Journal Article

    Gandham, A. R.; Geller, S.; Dusza, S. W.; Kupper, T. S.; Myskowski, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse national health and nutrition examination survey (NHANES) case-control study
    Meeting Abstract

    Joseph, J.; Tang, L.; Hillengass, J.; Landgren, O.; Usmani, S.; Lesokhin, A.; Moysich, K.; Shah, U.
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Mailankody, S.; Lahoud, O.; Landau, H.; Chung, D.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Whole genome sequencing reveals significant genetic admixture in multiple myeloma patients, impacting assessment of etiology
    Meeting Abstract

    Maclachlan, K.; Blaney, P.; Gagler, D.; Boyle, E.; Diamond, B.; Shah, U.; Korde, N.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Individualized risk in newly diagnosed multiple myeloma
    Meeting Abstract

    Maura, F.; Rajanna, A.; Ziccheddu, B.; Derkach, A.; Poos, A.; Maclachlan, K.; Boyle, E.; Hultcrantz, M.; Silva, A.; Jackson, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • CARTITUDE-1 final results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Jagannath, S.; Martin, T.; Usmani, S.; Berdeja, J.; Jakubowiak, A.; Agha, M.; Cohen, A.; Deol, A.; Htut, M.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Impact of hypogammaglobulinemia and immunoglobulin replacement therapy on infection rate in patients with RRMM treated with elranatamab: Post-hoc analysis from MagnetisMM-3
    Meeting Abstract

    Leleu, X.; Bahlis, N.; Rodríguez-Otero, P.; Quach, H.; Touzeau, C.; Depaus, J.; Iida, S.; Hänel, M.; Wrobel, T.; Leip, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save